Home 
Sólveig Óskarsdóttir
Sólveig ÓskarsdóttirSólveig Óskarsdóttir
Dr. Sólveig Óskarsdóttir graduated in Medicine at the University of Iceland in 1980. She moved to Gothenburg, Sweden 1984 and has been working at Queen Silvia Children's Hospital/Sahlgrenska University Hospital since then. She became a specialist in pediatrics 1990.
Dr. Óskarsdóttir became part of the Rheumatology and Immunology team in the early 1990s. In her clinical work she became engaged in patients with 22q11 deletion syndrome, which was a new and emerging group at that time. In 1997, she set up a multidisciplinary specialist-team to evaluate the different aspects of the disorder systematically. This was the starting point for a research project, and she successfully defended her PhD thesis, "The 22q11 deletion syndrome. A Clinical and Epidemiological Study", in 2005. The project resulted in several additional publications and two other PhD theses.
Another aim of Dr. Óskarsdóttir's project was to disseminate information and increase knowledge about the syndrome among professionals and families. She contributed to the establishment of a family and patient organisation in 2000 and became a member of its board. She continues to be highly involved in education and distribution activities organised by the association.
Dr. Óskarsdóttir has been following children and adolescents with the 22q11 deletion syndrome for nearly 30 years and is the leader of the 22q11-expert team at Sahlgrenska University Hospital in Gothenburg, Sweden.
Dr. Óskarsdóttir is a founding member of the 22q Society. Together with international colleagues, she participated in providing guidelines for management and follow-up of children with 22q11.2DS. Together with a group of professionals and parents, she is now developing national guidelines for Sweden.
Although Dr. Óskarsdóttir is officially retired, she still works part time, mostly on 22q11 deletion syndrome. She is currently involved in a research project which focusses on thymic function in patients with the syndrome. She also participates in an international multidisciplinary study together with many centres around the world.
Dr. Óskarsdóttir became part of the Rheumatology and Immunology team in the early 1990s. In her clinical work she became engaged in patients with 22q11 deletion syndrome, which was a new and emerging group at that time. In 1997, she set up a multidisciplinary specialist-team to evaluate the different aspects of the disorder systematically. This was the starting point for a research project, and she successfully defended her PhD thesis, "The 22q11 deletion syndrome. A Clinical and Epidemiological Study", in 2005. The project resulted in several additional publications and two other PhD theses.
Another aim of Dr. Óskarsdóttir's project was to disseminate information and increase knowledge about the syndrome among professionals and families. She contributed to the establishment of a family and patient organisation in 2000 and became a member of its board. She continues to be highly involved in education and distribution activities organised by the association.
Dr. Óskarsdóttir has been following children and adolescents with the 22q11 deletion syndrome for nearly 30 years and is the leader of the 22q11-expert team at Sahlgrenska University Hospital in Gothenburg, Sweden.
Dr. Óskarsdóttir is a founding member of the 22q Society. Together with international colleagues, she participated in providing guidelines for management and follow-up of children with 22q11.2DS. Together with a group of professionals and parents, she is now developing national guidelines for Sweden.
Although Dr. Óskarsdóttir is officially retired, she still works part time, mostly on 22q11 deletion syndrome. She is currently involved in a research project which focusses on thymic function in patients with the syndrome. She also participates in an international multidisciplinary study together with many centres around the world.